RCT of Olanzapine for Control of CIV in Children Receiving Highly Emetogenic Chemotherapy

Abroad (travel likely)RecruitingPHASE2

Conditions

Vomiting in Infants and/or Children · Nausea · Hematopoietic System--Cancer · Oncology

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of California, San Francisco, California, United States
Contact: Study coordinator (Kevin wu) · Kevin.Wu3@ucsf.edu
The Children's Mercy Hospital, Kansas City, Missouri, United States
Contact: Study coordinator (Judy Vun) · (816) 302-6797
Columbia University/Morgan Stanley Children's Hospital, New York, New York, United States
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
Contact: Study coordinator (Juanita Cuffee) · cuffee@med.unc.edu · (919) 966-0017
Nationwide Children's Hospital, Columbus, Ohio, United States
Contact: Study coordinator (Clelie Peck) · clelie.peck@nationwidechildrens.org
Medical University of South Carolina, Charleston, South Carolina, United States
Contact: Study coordinator (Shanta Salzer) · 843-792-1463
Cancer Care Manitoba, Winnipeg, Manitoba, Canada
Contact: Study coordinator (Kathy Hjalmarsson) · khjalmarsson@cancercare.mb.ca
Hospital for Sick Children, Toronto, Ontario, Canada
Contact: Study coordinator (Lee Dupuis, PhD) · lee.dupuis@sickkids.ca · 416-813-7654
Centre Hospitalier Universitaire Sainte-Justine,, Montreal, Quebec, Canada
All India Institute of Medical Sciences, New Delhi, National Capital Territory of Delhi, India
Contact: Study coordinator (Shuvadeep Ganguly) · Ganguly.Shuvadeep@gmail.com

Study leads

Lee Dupuis, RPh, PhD
Principal Investigator
The Hospital for Sick Children
Muhammad Ali, MD
Principal Investigator
The Hospital for Sick Children

View source on ClinicalTrials.gov